$INO ...it's been 112 days since they dosed their first patient with INO 4800 and 27 days since the release of their half ass data pr that No BP had interest in. IMO their data is not credible if they were unable to secure partnership and additional vaccine funding. Soon they will be crushed by everyone.
  • 2
  • 1
@Blade_runr Well you get it. The rest of the bulls on here are utter sheep. Their data has never been credible. The only thing going for INO in this race is that DNA is more stable than RNA at room temperature so their vaccines should have a better shelf life and be cheaper to transport in bulk. At this point in time, that's it. Pfizer is likely going to win this one.